Early-Onset Cancer: Incidence Up, Mortality Down – But Obesity a Growing Concern

Global rates of death from early-onset cancer—defined as cancers diagnosed in adults aged 15 to 49—have declined significantly over the past three decades, despite a slight increase in the overall incidence of these malignancies, according to research published March 26, 2026. The findings, published in an analysis of data from 204 countries, offer a cautiously optimistic outlook, though researchers emphasize the growing impact of risk factors like obesity.

A Complex Picture of Early-Onset Cancer

The study, led by Rupayan Kundu, MD, a resident physician at Cleveland Clinic, analyzed data from the Global Burden of Disease 2021 study. Researchers found that while the incidence of early-onset cancer increased by 3% globally between 1990 and 2021, mortality rates dropped by a substantial 17%. This suggests improvements in diagnosis, treatment, and potentially, preventative measures are having a positive effect, even as more cases are identified.

“It’s good news,” Dr. Kundu told Healio, noting the contrast between the “subtle” rise in diagnoses and the “significant” reduction in deaths. The research team investigated data on 31 different cancer types, defining early-onset cancer as diagnoses in individuals aged 15 to 49 years.

Rising Incidence in the U.S. And the Role of Screening

The increasing focus on early-onset cancer stems from a growing body of evidence highlighting its rise, particularly in the United States. An American Association for Cancer Research (AACR) Cancer Progress Report revealed that diagnoses increased for 14 different malignancies among individuals younger than 50 between 2010 and 2019.

Colorectal cancer has been a particularly concerning trend. Recent data show a 3% increase in colorectal cancer incidence among U.S. Adults aged 20 to 49 between 2013 and 2022. Healio reported on this shift, highlighting the demand for increased awareness and earlier screening.

Dr. Kundu suggests that much of the observed increase in incidence is likely attributable to improved screening practices and greater awareness among the public. “Previously, whenever we had a lot of symptoms, we didn’t travel to the doctors in the first place,” he explained. “Now, even if we have some symptoms, we are more aware that this might be a symptom of cancer.” However, he also acknowledges that research indicates genuine biological increases in early-onset cancer incidence, rather than simply better detection.

Obesity: A Growing Concern

While overall mortality rates from early-onset cancer have decreased, the study revealed a troubling trend: deaths related to obesity have risen substantially. Mortality linked to a high Body Mass Index (BMI) increased by nearly 93% between 1990 and 2021. This underscores the critical link between obesity and cancer risk, and the urgent need for preventative measures.

“There is a global epidemic in obesity, and we are seeing the effect right now,” Dr. Kundu stated. This finding aligns with other recent research, including a study published in February 2025, which demonstrated that remote intervention helped women with breast cancer and obesity lose nearly 5% of their body weight.

Global Variations and Specific Cancer Types

The study also highlighted geographical variations in cancer incidence and mortality. High-income North America experienced the greatest increase in incidence (74%), followed by Central Latin America (33%). Conversely, high-income Asia Pacific, Western Europe, and high-income North America saw the largest reductions in death rates (39%, 37%, and 36%, respectively).

Among specific cancer types, breast cancer accounted for the highest number of cases (567,903) and deaths (131,023) in the early-onset population. Other cancers with notable increases in incidence included prostate cancer, thyroid cancer, nonmelanoma skin cancer, and testicular cancer. Significant decreases in mortality were observed for Hodgkin lymphoma, leukemia, esophageal cancer, and lung cancers.

What Comes Next: Survivorship and Continued Surveillance

The researchers project that cancer incidence in the 15-49 age group will remain relatively stable, but deaths will continue to decline. However, they emphasize the importance of focusing on improving survivorship care. “We are seeing more people living with the cancer,” Dr. Kundu said. “A better survivorship program will help a lot in this population.”

The study acknowledges limitations, including reliance on modeled data. Nevertheless, the findings underscore the need for continued surveillance, research into the underlying causes of early-onset cancer, and the development of effective prevention and treatment strategies. Further investigation into the interplay between risk factors like obesity, lifestyle choices, and genetic predisposition will be crucial in mitigating the burden of early-onset cancer globally.

For more information: Rupayan Kundu, MD, can be reached at [email protected].